Patricia Castronuovo

Elbasvir/grazoprevir in children aged 3–18 years with chronic HCV genotype 1 or 4 infection: a pharmacokinetic modeling study

M. Pawłowska, M. Jonas, Robert H. Squires, 2023, Hepatology communications.